← Back to headlines
Immunovant Stock Rises 30% Despite Investor Trimming Stake
Immunovant stock surged by 30% even after an investor reduced their stake by $3 million, with analysts still maintaining a bullish outlook on the company.
11 Mar, 17:08 — 11 Mar, 17:08
Sources
Showing 1 of 1 sources
Related Stories
The war in Iran is pushing up mortgage rates. Here's how to lock in low borrowing costs
26m ago
The surge in oil prices is making Fed rate cuts harder to justify – economist
34m ago
Cliffwater private credit fund gets redemption requests totaling 14% - report
54m ago
The 10 most oversold S&P 500 stocks as markets digest the U.S.-Iran war
58m ago